A detailed history of Brr Op Co, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Brr Op Co, LLC holds 3,780 shares of SRPT stock, worth $404,913. This represents 0.05% of its overall portfolio holdings.

Number of Shares
3,780
Previous 3,823 1.12%
Holding current value
$404,913
Previous $287,000 45.64%
% of portfolio
0.05%
Previous 0.03%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022

SELL
$75.71 - $119.24 $3,255 - $5,127
-43 Reduced 1.12%
3,780 $418,000
Q2 2022

Aug 04, 2022

SELL
$62.69 - $88.44 $356,580 - $503,046
-5,688 Reduced 59.8%
3,823 $287,000
Q1 2022

May 05, 2022

BUY
$63.15 - $90.42 $361,912 - $518,197
5,731 Added 151.61%
9,511 $743,000
Q4 2021

Feb 07, 2022

SELL
$77.28 - $99.42 $482,304 - $620,480
-6,241 Reduced 62.28%
3,780 $340,000
Q3 2021

Nov 05, 2021

BUY
$65.97 - $92.48 $364,682 - $511,229
5,528 Added 123.04%
10,021 $927,000
Q2 2021

Aug 09, 2021

SELL
$69.38 - $86.75 $7,354 - $9,195
-106 Reduced 2.3%
4,493 $349,000
Q1 2021

May 12, 2021

SELL
$72.25 - $168.95 $670,985 - $1.57 Million
-9,287 Reduced 66.88%
4,599 $343,000
Q4 2020

Feb 10, 2021

BUY
$125.56 - $178.74 $307,245 - $437,376
2,447 Added 21.39%
13,886 $2.37 Million
Q3 2020

Nov 03, 2020

SELL
$127.12 - $172.34 $211,400 - $286,601
-1,663 Reduced 12.69%
11,439 $1.61 Million
Q2 2020

Aug 13, 2020

BUY
$93.0 - $171.7 $444,447 - $820,554
4,779 Added 57.42%
13,102 $2.1 Million
Q1 2020

May 07, 2020

BUY
$82.38 - $131.64 $138,645 - $221,550
1,683 Added 25.35%
8,323 $814,000
Q4 2019

Jan 31, 2020

BUY
$76.53 - $135.58 $254,232 - $450,396
3,322 Added 100.12%
6,640 $857,000
Q3 2019

Nov 12, 2019

SELL
$72.81 - $156.91 $297,210 - $640,506
-4,082 Reduced 55.16%
3,318 $250,000
Q2 2019

Aug 14, 2019

BUY
$112.21 - $151.95 $511,453 - $692,588
4,558 Added 160.38%
7,400 $1.12 Million
Q1 2019

Apr 26, 2019

BUY
$106.67 - $151.68 $303,156 - $431,074
2,842 New
2,842 $339,000

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $9.38B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Brr Op Co, LLC Portfolio

Follow Brr Op Co, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brr Op Co, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brr Op Co, LLC with notifications on news.